Safety and Proof-of-Concept Efficacy of Inhaled Drug Loaded Nano- and Immunonanoparticles in a c-Raf Transgenic Lung Cancer Model

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|1|11-29

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.1, 2013-01, pp. : 11-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Early Efficacy Endpoints for Proof-of-Concept Trials

By Chen Cong  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 413-424

Taylor & Francis Ltd

Access to resources Recommend Favorite

Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments

By  

Current Pharmaceutical Design, Vol. 23, Iss. 3, 2017-02 ,pp. : 481-494

Bentham Science Publishers

Access to resources Recommend Favorite

Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model

By Khan Masood A.   Faisal S.M.   Mohammad Owais  

Journal of Drug Targeting, Vol. 14, Iss. 4, 2006-05 ,pp. : 233-241

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Inhaled and Intranasal Corticosteroids

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 13, Iss. 2, 2014-08 ,pp. : 83-87

Bentham Science Publishers

Access to resources Recommend Favorite

When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3788-3796

Bentham Science Publishers

Access to resources Recommend Favorite